Slc30A10 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Slc30A10 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Solute Carrier Family 30 Member 10 | |
|---|---|
| Gene Symbol | SLC30A10 |
| Full Name | Solute Carrier Family 30 Member 10 |
| Chromosome | 1q31.3 |
| NCBI Gene ID | 55532 |
| OMIM | 611410 |
| Ensembl ID | ENSG00000104679 |
| UniProt ID | Q6XR72 |
| Associated Diseases | Parkinsonism-Dystonia, Manganese Metabolism Disorder |
SLC30A10 (ZnT10) is a manganese and zinc transporter localized to the plasma membrane. It is expressed in neurons and astrocytes and is crucial for manganese efflux.
High expression in brain, especially basal ganglia.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Parkinsonism-Dystonia | Various | Variable | Altered function |
Slc30A10 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Slc30A10 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.